Somatic symptom disorder (SSD) is a DSM-5 diagnosis replacing several previous somatoform disorders. The criteria represent an important conceptual shift: SSD requires persistent somatic symptoms PLUS clinically significant excessive thoughts, feelings, or behaviors related to them. The disorder is the response to the symptoms, not whether the symptoms have identifiable medical cause.
DSM-5 criteria: (1) one or more distressing somatic symptoms; (2) excessive thoughts, feelings, or behaviors related to symptoms or associated health concerns, manifested by at least one of: disproportionate and persistent thoughts about seriousness of symptoms, persistently high anxiety about health or symptoms, excessive time and energy devoted to symptoms or health concerns; (3) persistent symptomatic state (typically >6 months).
The conceptual shift from older somatoform disorder framework:
Old framework required symptoms to be "medically unexplained" — driving extensive workup to rule out medical causes, sometimes missing the dual diagnosis where real medical illness coexists with disproportionate psychological response, and leaving clinicians and patients frustrated with diagnoses defined by absence.
New framework focuses on the psychological response to symptoms, not the symptoms' medical explanation. The disorder is the response, which can coexist with real medical illness. Allows treatment of the psychological aspect even when medical pathology is also present.
Clinical presentation: patient with persistent somatic symptoms — pain, fatigue, GI complaints, neurologic symptoms — and excessive worry, healthcare-seeking, disability behavior, and dysfunction. Often: many providers, many tests, many specialty referrals. Disproportionate distress and time commitment to the symptoms. The symptoms may or may not have identifiable medical cause; either way, the response is the diagnosable disorder.
Treatment approach — primary care medical home model:
Regular scheduled visits rather than symptom-driven visits — predictable contact reduces the perceived need for additional ED visits or specialist consultations.
Single primary clinician — consistency builds trust and prevents conflicting evaluations.
Minimize procedures and specialty referrals — each new workup tends to reinforce illness behavior without producing therapeutic benefit.
Validate symptoms while not over-investigating — "I believe your symptoms are real and distressing; we don't need additional testing for that to be true."
Treat comorbid mood/anxiety — substantial improvement in SSD often follows treatment of underlying depression or anxiety.
CBT focused on illness behavior — addresses cognitive distortions about symptoms, behavioral patterns, healthcare-seeking. Substantial evidence for SSD outcomes.
Mindfulness-based approaches for chronic pain and somatic preoccupation.
Pharmacotherapy: SSRIs help when comorbid depression/anxiety contribute. Duloxetine for somatic symptoms with comorbid pain has specific evidence. Avoid escalating opioids, benzodiazepines, or polypharmacy that often accumulates in this population.
Prognosis: often chronic but improvable with consistent care. The goal is functional improvement and reduced healthcare overuse rather than complete symptom resolution. Many patients improve substantially when they have a stable medical home approach instead of fragmented crisis-driven care.
When you encounter a patient with persistent somatic symptoms plus excessive illness-related thoughts, feelings, or behaviors, SSD is the diagnosis. Treatment is real and effective; the framework matters because it allows movement past the "we ruled everything out" impasse.